356 related articles for article (PubMed ID: 33574689)
1. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
Liu F; Wu H
J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
[TBL] [Abstract][Full Text] [Related]
2. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
Yin Z; Ma T; Chen S; Yu M
Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K
Front Oncol; 2021; 11():711402. PubMed ID: 34497764
[TBL] [Abstract][Full Text] [Related]
4. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
Liu F; Wu H
J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma.
Wang K; Li R; Zhang Y; Qi W; Fang T; Yue W; Tian H
Int J Gen Med; 2022; 15():2283-2300. PubMed ID: 35250303
[TBL] [Abstract][Full Text] [Related]
6. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
8. Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma.
Ying J; Hong H; Yu C; Jiang M; Ding D
Medicine (Baltimore); 2023 Sep; 102(38):e34954. PubMed ID: 37746997
[TBL] [Abstract][Full Text] [Related]
9. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
10. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer.
Lei P; Wang H; Yu L; Xu C; Sun H; Lyu Y; Li L; Zhang DL
Int Immunopharmacol; 2022 Jul; 108():108743. PubMed ID: 35413679
[TBL] [Abstract][Full Text] [Related]
11.
Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
[TBL] [Abstract][Full Text] [Related]
12. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.
Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ
J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207
[TBL] [Abstract][Full Text] [Related]
13. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
Zhang X; Wu Z; Ma K
BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
Wei Q; Miao T; Zhang P; Jiang B; Yan H
Front Genet; 2022; 13():984575. PubMed ID: 36159963
[No Abstract] [Full Text] [Related]
15. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma.
Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S
J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453
[TBL] [Abstract][Full Text] [Related]
16. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
17. SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma.
Liu G; Li F; Chen M; Luo Y; Dai Y; Hou P
Front Genet; 2022; 13():813285. PubMed ID: 35356432
[No Abstract] [Full Text] [Related]
18. Comprehensive Analysis of Aquaporin Superfamily in Lung Adenocarcinoma.
Lin G; Chen L; Lin L; Lin H; Guo Z; Xu Y; Hu C; Fu J; Lin Q; Chen W; Zeng Y; Xu Y
Front Mol Biosci; 2021; 8():736367. PubMed ID: 34708074
[No Abstract] [Full Text] [Related]
19. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma.
Bian J; Xiong W; Yang Z; Li M; Song D; Zhang Y; Liu C
Sci Rep; 2024 Jan; 14(1):522. PubMed ID: 38177255
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma.
Pan M; Huang P; Li L; Lei P; Fang L; Zhao L; Li Y; Huang S; Luo W
J Thorac Dis; 2023 Apr; 15(4):1872-1891. PubMed ID: 37197486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
